Methallenestril

Methallenestril
IUPAC name 3-(6-Methoxynaphthalen-2-yl)-2,2-dimethylpentanoic acid
Other names Methallenestrol
Identifiers
CAS number	517-18-0
PubChem	10599
Jmol-3D images	Image 1
SMILES CCC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(C)(C)C(=O)O
Properties
Molecular formula	C18H22O3
Molar mass	286.36548
Y (verify) (what is: Y/N?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

Methallenestril is an estrogen.^[1]

References

1. ^ Herbai G, Ljunghall S (1983). "Normalization of hypercalcaemia of primary hyperparathyroidism by treatment with methallenestril, a synthetic oestrogen with low oestrogenicity". Urol. Int. 38 (6): 371–3. PMID 6659184. 

Antiprogestin/
SPRM

antagonist: Mifepristone

Asoprisnil • CDB-4124  • Ulipristal acetate

Estrogens

Agonist	Steroidal Diosgenin • Estradiol (Ethinylestradiol#/Mestranol • Estradiol 17 beta-cypionate# • Polyestradiol phosphate) • Estrone (Estrone sulfate) • Estriol • Promestriene • Equilenin • Equilin Nonsteroidal Chlorotrianisene • Dienestrol • Fosfestrol • Diethylstilbestrol • Zeranol
Antiestrogen/ SERM	Afimoxifene • Arzoxifene • Bazedoxifene • Cyclofenil • Lasofoxifene • Ormeloxifene • Raloxifene • Tamoxifen • Toremifene Clomifene# • Mepitiostane • Nafoxidine pure antagonist: Fulvestrant
Aromatase inhibitors	nonselective: Aminoglutethimide • Testolactone selective: Anastrozole • Atamestane • Exemestane • Fadrozole • Formestane • Letrozole • Vorozole

^#WHO-EM. ^‡Withdrawn from market. Clinical trials: ^†Phase III. ^§Never to phase III

M: ♀ FRS anat/phys/devp noco/cong/npls, sysi/epon proc/asst, drug (G1/G2B/G3CD)